Stimulating Regulatory Science
We need better tools for assessing new medicines – and to develop them, we must work together.
Jan Johannessen, Ameeta Parekh |
The FDA defines regulatory science as the “science of developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of all FDA-regulated products.” FDA scientists have a unique vantage point from which to survey the drug development landscape. This collective regulatory knowledge can be leveraged to better understand the needs and opportunities for tools, standards and approaches in drug development. We believe advances in regulatory science are essential for the efficient development of new treatments and improved use of existing medicines.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!